The New Economics of Medical Practices in 2026

I have spent decades on the payer side of the table, and these days I spend most of my time on the other side of it, sitting across from physician groups all over the country. From that vantage point one thing has become impossible to miss. The economics of running a medical practice have not drifted. They have been rebuilt from the foundation up.

A lot of operators are still running their businesses off a map that was drawn five or ten years ago. Add volume, hold reimbursement steady, tighten operations a little each year, and the numbers used to work out. In 2026 that map leads straight off a cliff. Margins are not thinning because patients stopped coming through the door. They are thinning because the rules that govern reimbursement, cost structure, and competition all moved at the same time.

Revenue Growth Is No Longer Proof of Anything

For a long time, growth was simple arithmetic. Add providers, add visits, add locations, and revenue followed close behind. That equation has quietly broken.

We see it constantly now. A practice grows its top line while EBITDA sits flat or slides backward. The cause is not a mystery. Reimbursement per encounter is being squeezed while operating costs keep climbing.

Volume can paper over that gap for a while, the way a rising tide hides the rocks, but eventually the water goes out and the rocks are still sitting there. It is the same pattern that surfaces when you take performance apart metric by metric, a busy schedule paired with a disappointing financial result, which is exactly the theme we walk through in 5 Metrics Every Medical Practice Owner Should Track Weekly.

In this environment, growth without pricing discipline does not solve the problem. It pours fuel on it.

Payers Are Holding the Better Hand of Cards

The single biggest change in the market is the explosion of pricing transparency. Payers can now see, in fine detail, what providers are paid across every market, and they are putting that information to work.

They know precisely where reimbursement runs above market, where a group has little leverage, and where a contract can be quietly walked downward. Meanwhile a lot of practices are still negotiating from memory and stale benchmarks, which is a little like sitting down to a card game without ever looking at your own hand.

The result is a slow leak rather than a blowout. Contracts drift below market a few points at a time, and nobody notices until the compression shows up in the financials. The groups that come out ahead are the ones using data to benchmark and renegotiate on their own schedule, not the ones reacting after the margin is already gone.

Silence Gets Priced In

There is a quieter reason payers hold the advantage, and it has nothing to do with technology. Most medical groups simply do not talk to their payers about rates. The contract gets signed, it goes in a drawer, and everyone moves on to the work of running the practice. Five years pass. Then ten. It is not unusual for us to open a book of business and find agreements older than the youngest physician in the group.

A contract that nobody asks about is a contract that nobody prioritizes. Payers manage their renegotiation calendars the way an air traffic controller manages a runway, and the groups that never call in never get cleared for landing. If you are not pushing, you are not on the list, and the list is where the money is.

The part that costs the most is the part nobody sees. Payers set their reserves and trend allowances years in advance. They decide today what next year's rate movement looks like, and the year after that, and the one after that. A group that has been silent for a decade simply does not get a line item in that forecast. No pool of money is quietly waiting for it, because the payer never built one. So when that group finally walks up to the table, it is not asking for its share of a budgeted increase. It is asking the payer to find money that was never set aside in the first place, which is a far harder conversation and a far smaller check.

The lesson is uncomfortable but simple. Going quiet does not hold your position. It quietly lowers it.

The Cost Base Has Reset, and It Is Not Going Back

On the other side of the ledger, costs have changed in a way that feels permanent. Labor is more expensive. Administrative complexity is heavier. Working denials, authorizations, and payer requirements takes more people and more hours than it did even a few years ago.

These are not storms that blow through. They are the new sea level. Waiting for costs to recede is not a plan. Margin has to be rebuilt the hard way, through better reimbursement, cleaner revenue capture, and sharper execution.

Scale Is an Engine, Not a Result

Consolidation has produced larger and more sophisticated platforms with real structural advantages, including negotiating leverage, broader market presence, and the ability to invest in infrastructure.

But scale by itself does not create value. It is an engine, and an engine that nobody connects to the wheels just makes noise.

Across multisite groups we see the same things again and again. Wide variation in reimbursement for the identical service. Payer contracts scattered location by location with no common thread. No central strategy tying negotiation and rate alignment together.

That gap is where the real money is sitting. Without a disciplined payer strategy, scale only adds complexity and leaves the benefit on the table. With the right execution behind it, scale becomes one of the most powerful levers a group has for expanding margin.

Revenue Quality Is the Metric That Matters Now

The strongest organizations have changed what they put on the dashboard. Instead of staring at volume, they watch revenue quality, meaning what they actually earn and collect for every unit of care they deliver.

That shift lives in a short list of numbers. Reimbursement per encounter. Net collection rate. Denial adjusted yield. Performance broken out by payer and by contract.

These are the metrics that drive real decisions. They force the hard questions into the open. Are the contracts aligned with what the market actually pays, and are the operational processes capturing the full value of the agreements that are already signed. They also point to the cleanest path toward EBITDA that grows and then stays grown.

Where Accretive Health Advisors Comes In

None of this is theory. It shows up in the data with uncomfortable clarity. Most groups are not underperforming because demand softened or because the medicine slipped. They are underperforming because they cannot see what their contracts should be paying, and they have no structured way to close the difference.

At Accretive Health Advisors we work with multisite physician groups and private equity backed platforms to turn that blur into a clear picture. We benchmark reimbursement at the CPT level against market data drawn from hundreds of millions of posted rates, find the contracts that are quietly underperforming, and build payer negotiation strategies that hold up under pressure and move rates in a direction you can actually defend.

As the pricing landscape keeps shifting, that kind of visibility stops being a nice extra and becomes a genuine competitive edge, a theme we keep returning to across the Accretive Health Advisors Blog.

Just as important, we make sure those wins land as actual cash in the account. That means matching revenue cycle processes to the contract terms, sealing the leaks from denials and underpayments, and bringing consistency across every location so that a dollar earned in one market is a dollar earned in all of them. For scaled platforms we go a step further and harmonize rates across markets, so the organization finally gets paid for the size it worked so hard to build.

If you run a specialty group or a multisite platform and you suspect your contracts are paying less than they should, that suspicion is worth putting to the test. We built our entire practice around finding that gap and closing it, and we do it on a model where our success is tied to yours. The economics of 2026 reward visibility, discipline, and execution. We would welcome the chance to bring all three to your organization, ideally before the next contract cycle makes the decision for you.